EMEA-000365-PIP01-08-M12

Table of contents

Key facts

Invented name
Tamiflu
Active substance
Oseltamivir (phosphate)
Therapeutic area
Infectious diseases
Decision number
P/0241/2021
PIP number
EMEA-000365-PIP01-08-M12
Pharmaceutical form(s)
  • Capsule, hard
  • Powder for oral suspension
Condition(s) / indication(s)
Treatment and prevention of influenza
Route(s) of administration
Oral use
Contact for public enquiries
Roche Registration GmbH

E-mail: info.paediatrics@roche.com
Tel. +41 616879411

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000365-PIP01-08-M12
Compliance opinion date
15/10/2021
Compliance outcome
positive

Decision

Related content

How useful was this page?

Add your rating
Average
1 rating